Form 4: National Healthcare Corp Executive Ben Anderson Flatt, Sr. Awarded Stock Options
SEC Form 4
Senior VP & CIO of National Healthcare Corp, Ben Anderson Flatt, Sr., reports the grant of stock options for 13,500 shares of common stock.
Summary
- Ben Anderson Flatt, Sr., Senior VP & CIO of National Healthcare Corp, filed a Form 4 on February 26, 2025.
- The filing reports the grant of options to purchase 13,500 shares of National Healthcare Corp common stock at an exercise price of $90.62 on February 24, 2025.
- These options vest ratably over three years, starting February 24, 2026.
- Flatt directly owns 11,896.0547 shares of common stock.
- He also holds options to purchase 3,734 shares at $63.96, 7,467 shares at $53.94 and 12,000 shares at $94.1.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders.
Future Outlook
The executive's future compensation is tied to the performance of the company's stock.
Industry Context
Stock option grants are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are generally benchmarked against peer companies in the healthcare sector.
- Companies like Brookdale Senior Living and Five Star Senior Living also utilize stock options as part of their executive compensation plans.
- The vesting schedules and exercise prices are typically structured to incentivize long-term performance and retention.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it aligns management's interests with the company's long-term success.
- Employees may see this as a positive sign of the company investing in its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date exercisable for options to purchase 3,734 shares at $63.96 |
| 02/18/2027 | Expiration date for options to purchase 3,734 shares at $63.96 |
| 03/08/2024 | Date exercisable for options to purchase 7,467 shares at $53.94 |
| 03/08/2028 | Expiration date for options to purchase 7,467 shares at $53.94 |
| 03/05/2025 | Date exercisable for options to purchase 12,000 shares at $94.1 |
| 03/05/2029 | Expiration date for options to purchase 12,000 shares at $94.1 |
| 02/24/2025 | Date of grant for options to purchase 13,500 shares at $90.62 |
| 02/24/2026 | First vesting date for options to purchase 13,500 shares at $90.62 (1/3 vest) |
| 02/24/2027 | Second vesting date for options to purchase 13,500 shares at $90.62 (1/3 vest) |
| 02/24/2028 | Final vesting date for options to purchase 13,500 shares at $90.62 (1/3 vest) |
| 02/24/2030 | Expiration date for options to purchase 13,500 shares at $90.62 |
| 02/26/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.